Zim Laboratories
Zim Laboratories Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Zim Laboratories
Start SIPZim Laboratories Investment Rating
-
Master Rating:
-
Zim Laboratories has an operating revenue of Rs. 398.53 Cr. on a trailing 12-month basis. An annual revenue growth of 20% is outstanding, Pre-tax margin of 9% is okay, ROE of 12% is good. The company has a reasonable debt to equity of 12%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 16% and 11% from 50DMA and 200DMA. It is currently FORMING a base in its weekly chart and is trading around 20% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 54 which is a POOR score indicating inconsistency in earnings, a RS Rating of 71 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 103 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 104 | 100 | 99 | 93 | 104 |
| Operating Expenses Qtr Cr | 89 | 88 | 87 | 81 | 90 |
| Operating Profit Qtr Cr | 15 | 13 | 12 | 11 | 14 |
| Depreciation Qtr Cr | 5 | 4 | 4 | 4 | 4 |
| Interest Qtr Cr | 1 | 2 | 1 | 1 | 1 |
| Tax Qtr Cr | 3 | 3 | 3 | 2 | 4 |
| Net Profit Qtr Cr | 7 | 7 | 6 | 6 | 6 |
Zim Laboratories Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹94.05
- 50 Day
- ₹88.21
- 100 Day
- ₹86.67
- 200 Day
- ₹83.75
- 20 Day
- ₹93.04
- 50 Day
- ₹84.15
- 100 Day
- ₹83.85
- 200 Day
- ₹88.15
Zim Laboratories Resistance and Support
| Resistance | |
|---|---|
| First Resistance | ₹101.73 |
| Second Resistance | ₹104.79 |
| Third Resistance | ₹107.58 |
| RSI | 65.71 |
| MFI | 74.39 |
| MACD Single Line | 4.52 |
| MACD | 4.85 |
| Support | |
|---|---|
| First Resistance | ₹95.88 |
| Second Resistance | ₹93.09 |
| Third Resistance | ₹90.03 |
Zim Laboratories Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 63,577 | 5,357,634 | 84.27 |
| Week | 152,421 | 12,047,356 | 79.04 |
| 1 Month | 78,068 | 5,876,921 | 75.28 |
| 6 Month | 27,650 | 1,941,863 | 70.23 |
Zim Laboratories Result Highlights
Zim Laboratories Synopsis
NSE-Medical-Generic Drugs
Zim Laboratories is involved in the business activities of Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 396.53 Cr. and Equity Capital is Rs. 48.73 Cr. for the Year ended 31/03/2023. Zim Laboratories Ltd. is a Public Limited Listed company incorporated on 14/02/1984 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1984PLC032172 and registration number is 032172.| Market Cap | 498 |
| Sales | 397 |
| Shares in Float | 3.26 |
| No of funds | 1 |
| Yield |
| Book Value | 2.57 |
| U/D Vol ratio | 1.3 |
| LTDebt / Equity | 13 |
| Alpha | 0.16 |
| Beta | 0.46 |
Zim Laboratories
| Owner Name | Mar-23 | Dec-22 | Sep-22 | Jun-22 |
|---|---|---|---|---|
| Promoters | 33.26% | 33.26% | 33.26% | 33.26% |
| Foreign Portfolio Investors | ||||
| Individual Investors | 51.58% | 51.57% | 50.96% | 51.15% |
| Others | 15.16% | 15.17% | 15.78% | 15.59% |
Zim Laboratories Management
| Name | Designation |
|---|---|
| Dr. Anwar Daud | Chairman & Managing Director |
| Mr. Zulfiquar M Kamal | Director - Finance |
| Mr. Prakash Sapkal | Director - Operations |
| Mr. Niraj Dhadiwal | Director - Business Development |
| Mr. Padmakar Joshi | Independent Director |
| Dr. Kamlesh Shende | Independent Director |
| Dr. Kakasaheb Mahadik | Independent Director |
| Mrs. Kavita Loya | Independent Director |
Zim Laboratories Forecast
Price Estimates
Zim Laboratories Corporate Action
Zim Laboratories FAQs
What is Share Price of Zim Laboratories ?
Zim Laboratories share price is ₹102 As on 02 June, 2023 | 00:03
What is the Market Cap of Zim Laboratories ?
The Market Cap of Zim Laboratories is ₹501.2 Cr As on 02 June, 2023 | 00:03
What is the P/E ratio of Zim Laboratories ?
The P/E ratio of Zim Laboratories is 20.5 As on 02 June, 2023 | 00:03
What is the PB ratio of Zim Laboratories ?
The PB ratio of Zim Laboratories is 2.5 As on 02 June, 2023 | 00:03